Frontiers in Immunology (Jun 2023)

The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis

  • Shuai Peng,
  • Shuai Peng,
  • Lei Shen,
  • Lei Shen,
  • Xiaoyun Yu,
  • Li Zhang,
  • Ke Xu,
  • Yuan Xia,
  • Yuan Xia,
  • Lanlan Zha,
  • Lanlan Zha,
  • Jing Wu,
  • Jing Wu,
  • Hesheng Luo,
  • Hesheng Luo

DOI
https://doi.org/10.3389/fimmu.2023.1200111
Journal volume & issue
Vol. 14

Abstract

Read online

Ulcerative colitis (UC) is a chronic inflammatory bowel disease involving mainly the colorectal mucosa and submucosa, the incidence of which has been on the rise in recent years. Nuclear factor erythroid 2-related factor 2 (Nrf2), known for its key function as a transcription factor, is pivotal in inducing antioxidant stress and regulating inflammatory responses. Numerous investigations have demonstrated the involvement of the Nrf2 pathway in maintaining the development and normal function of the intestine, the development of UC, and UC-related intestinal fibrosis and carcinogenesis; meanwhile, therapeutic agents targeting the Nrf2 pathway have been widely investigated. This paper reviews the research progress of the Nrf2 signaling pathway in UC.

Keywords